EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS10 - Drug allergy 1

Friday 31 May, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
Abstract Text
D1.156
Anaphylactic shock after rosuvastatin with basophil activation test positive
Abstract Text
D1.157
Anaphylaxis during chemotherapy: when premedication is the problem
Abstract Text
D1.168
Anaphylaxis induced by carboxymethylcellulose injection: case report with evaluation of oral and nasal tolerance
Abstract Text
D1.159
DON'T GET LABELLED - Betalactamic Allergy labelling in patients admitted to 3rd level hospitals
Abstract Text
D1.165
Decoding adverse reactions to contrast media: a comprehensive study from Chile
Abstract Text
D1.163
Desensitization to Natalizumab in a patient with Multiple Slcerosis
Abstract Text
D1.164
Drug-Induced Enterocolitis Syndrome (DIES) to amoxicillin, confirmed with a lymphocyte transformation test
Abstract Text
D1.155
Hypersensitivity Reactions to Contrast Media: Reality from a Portuguese Tertiary Hospital
Abstract Text
D1.166
If one must choose to be allergic to a beta-lactam, you'd better choose cefazolin
Abstract Text
D1.154
Integration of beta-lactam allergic evaluation in an antibiotic sterwardship program
Abstract Text
D1.160
Riddles of drug hypersensitivity diagnosis: a case series
Abstract Text
D1.167
The First Case Report of 12-Step 3-Bag Successful Rapid Drug Desensitization to Daratumumab in a Patient with Renal Failure Due to Secondary Systemic Amyloid and Plasma Cell Dyscrasia
Abstract Text
D1.158
Unveiling the Impact of NSAIDs Hypersensitivity Reactions: A Tertiary Hospital Perspective

Chairs

Speakers